A motilin agonist, erythromycin, decreases circulating growth hormone levels in normal subjects but not in diabetic subjects (Q79311532)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 November 2006
edit
Language Label Description Also known as
English
A motilin agonist, erythromycin, decreases circulating growth hormone levels in normal subjects but not in diabetic subjects
scientific article published on 01 November 2006

    Statements

    A motilin agonist, erythromycin, decreases circulating growth hormone levels in normal subjects but not in diabetic subjects (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit